Figure 3
Examples of time courses of the proteomics diagnosis based on the aGvHD pattern. The SVM-based classification factor F (FGvHD) is plotted against the days before and after HSCT starting prior to conditioning treatment (day −10). The threshold was chosen at classification factor FGvHD = 0.2, as indicated by a line; values above indicate GvHD. The resulting curve is shown for individual patients. (A) Patient 2791 was diagnosed with GvHD grade II on day +27. The classification factor score was 0.8 on day +20 after HSCT, 7 days prior to clinical diagnosis, and returned to inconspicuous values at day +41, reflecting response to treatment. (B) Patient 2725 was diagnosed with GvHD grade III of the skin on day +25 after HSCT. Classification factor F rose to 0.5, thus indicating aGvHD. The initial response to steroid treatment led to the normalization of the factor value on day +55, with no change due to a reactivation of CMV at about day +60 after HSCT. The next rise of the classification factor was concerted with cGvHD (BOOP). (C) Patient 3264 did not develop aGvHD, thus representing an example of a negative control. The values remain around baseline well below the aGvHD cutoff number of 0.2 throughout the observation period.

Examples of time courses of the proteomics diagnosis based on the aGvHD pattern. The SVM-based classification factor F (FGvHD) is plotted against the days before and after HSCT starting prior to conditioning treatment (day −10). The threshold was chosen at classification factor FGvHD = 0.2, as indicated by a line; values above indicate GvHD. The resulting curve is shown for individual patients. (A) Patient 2791 was diagnosed with GvHD grade II on day +27. The classification factor score was 0.8 on day +20 after HSCT, 7 days prior to clinical diagnosis, and returned to inconspicuous values at day +41, reflecting response to treatment. (B) Patient 2725 was diagnosed with GvHD grade III of the skin on day +25 after HSCT. Classification factor F rose to 0.5, thus indicating aGvHD. The initial response to steroid treatment led to the normalization of the factor value on day +55, with no change due to a reactivation of CMV at about day +60 after HSCT. The next rise of the classification factor was concerted with cGvHD (BOOP). (C) Patient 3264 did not develop aGvHD, thus representing an example of a negative control. The values remain around baseline well below the aGvHD cutoff number of 0.2 throughout the observation period.

Close Modal

or Create an Account

Close Modal
Close Modal